Biological effects of recombinant vaccinia virus-expressed interleukin 4
- PMID: 1515552
- DOI: 10.1016/1043-4666(92)90068-3
Biological effects of recombinant vaccinia virus-expressed interleukin 4
Erratum in
- Cytokine 1993 Jan;5(1):89
Abstract
Recombinant vaccinia viruses expressing murine interleukin 4 (IL-4), either alone or together with interleukin 2 (IL-2) or gamma interferon (gamma-IFN), were constructed. Unlike IL-2, IL-4 expressing viruses were not cleared from immunodeficient mice and the mice died. As they died more rapidly than immunodeficient mice inoculated with a control virus, it appeared that IL-4 contributed to their death and the IL-4 mediated toxicity was confirmed in normal immunocompetent mice. The toxicity was reversed by co-expression of either IL-2 or gamma-IFN, probably due to virus clearance and therefore lower levels of circulating IL-4. Vaccinia virus-expressed IL-4 did not increase antibody or natural killer cell levels and caused a slight decrease in cytotoxic T lymphocyte levels.
Similar articles
-
Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma.Eur J Immunol. 1990 Jan;20(1):157-61. doi: 10.1002/eji.1830200123. Eur J Immunol. 1990. PMID: 2106440
-
Effects of vaccinia virus-expressed interleukin 2 on the immune system of sublethally irradiated mice.Microb Pathog. 1991 May;10(5):363-71. doi: 10.1016/0882-4010(91)90081-k. Microb Pathog. 1991. PMID: 1753876
-
Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo.J Virol. 1996 Oct;70(10):7103-7. doi: 10.1128/JVI.70.10.7103-7107.1996. J Virol. 1996. PMID: 8794356 Free PMC article.
-
Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice.J Immunol. 1991 Dec 15;147(12):4327-32. J Immunol. 1991. PMID: 1684375
-
Coevolution of hosts and microorganisms: an analysis of the involvement of cytokines in host-parasite interactions.Mem Inst Oswaldo Cruz. 1992;87 Suppl 5:11-21. doi: 10.1590/s0074-02761992000900002. Mem Inst Oswaldo Cruz. 1992. PMID: 1342705 Review.
Cited by
-
Development of the small-molecule antiviral ST-246 as a smallpox therapeutic.Future Virol. 2011 May;6(5):653-671. doi: 10.2217/fvl.11.27. Future Virol. 2011. PMID: 21837250 Free PMC article.
-
NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.J Virol. 2002 May;76(9):4294-303. doi: 10.1128/jvi.76.9.4294-4303.2002. J Virol. 2002. PMID: 11932395 Free PMC article.
-
Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination.Vaccine. 2008 Feb 13;26(7):933-46. doi: 10.1016/j.vaccine.2007.11.095. Epub 2007 Dec 26. Vaccine. 2008. PMID: 18226434 Free PMC article.
-
Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy.Virology. 2011 Jan 20;409(2):328-37. doi: 10.1016/j.virol.2010.10.021. Epub 2010 Nov 10. Virology. 2011. PMID: 21071055 Free PMC article.
-
Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.J Virol. 2001 Feb;75(3):1205-10. doi: 10.1128/JVI.75.3.1205-1210.2001. J Virol. 2001. PMID: 11152493 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials